DOCSLIB.ORG

Collagen Peptides – Innovative Technologies for Innovative Ideas! What Are Collagen Peptides?

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Collagen Peptides – Innovative Technologies for Innovative Ideas! What Are Collagen Peptides? Collagen Peptides – Innovative technologies for innovative ideas! What are Collagen Peptides? Collagen Peptides are functional digested and fully utilized by the body. Collagen Peptides are also non-allergenic short chains of amino acids produced and suitable for clean label products. by the simple hydrolysis of collagen GELITA offers a versatile portfolio of different protein. Depending on the applied Collagen Peptides, including specific Bioactive Collagen Peptides®, which are optimized for enzymatic process, Collagen Peptides targeted health benefits e. g. FORTIBONE® for will deliver excellent solutions for Bone Health or VERISOL® for Beauty from within and TENDOFORTE® for Ligaments & Tendons. food applications and specific health Collagen Peptides are a pure source of protein benefits. that originates from collagen, a mammalian extracellular matrix protein. Collagen Peptides are characterized by their Due to their unique functionality GELITA® particular molecular weight distribution profile Collagen Peptides are ideal protein solutions to and high bioavailability. They are pure sources of combine with other food ingredients for a variety collagen protein amino acids that are rapidly of food and health & nutrition applications. Pretreatment of the Raw Material Enzymatic Process Purification (Hydrolysis of collagen (Filtration, Demineralization) into specific peptides) Enzyme Blend pH Temper- Time ature Separation Thermal/ Specific and Chemical controlled Hydrolysis enzymatic hydrolysis Native collagen Bioactive in raw material Collagen Peptides® [2] GELITA® Collagen Peptide Portfolio Beauty from Within Advantages in food applications Joint Health Human • Excellent solubility Pet • Heat-stability • Stable against food acids Bone Health • Brilliant clarity Ligaments & Tendons • No precipitation or flocculation Body Toning in liquid applications • Low viscosity Endurance • Neutral in taste and odor Protein Enrichment GELITA® Collagen Peptides are tailor made proteins fashioned by a safe and certified production process (ISO 9001, ISO 14001, ISO 50001 & FSSC 22000). GELITA’s portfolio also includes PEPTIPLUS®, a family The key of this technology is the enzymatic step of Collagen Peptide products, specialized for protein cutting the collagen into specific peptides. enrichment and technical food applications. Concentration Sterilization Spray Dryer UHT Flow of raw materials or products Packing, Storage Joints Finished product Automatic packing warehousing Specific and Bones Thermal/ Chemical controlled Hydrolysis enzymatic Muscles hydrolysis Skin Ligaments Native collagen Bioactive in raw material Collagen Peptides® [3] Why to use GELITA® Collagen Peptides? Collagen is a major component of the human Bioactive Collagen Peptides® body – making up about 30 % of our total body stimulate collagen metabolism protein. Collagen is crucial for mobile joints, stable bones, healthy muscles, strong ligaments GELITA Bioactive Collagen Peptides® (BCPs) and tendons, smooth skin, glossy hair and healthy include a range of specific peptides optimized finger nails. It is one of the primary structural for targeted health benefits. They directly stimu- proteins of connective tissues and also abundant late the metabolism of target connective tissue in blood vessels, intervertebral discs, the blood- cells involved in collagen biosynthesis. Further- brain barrier, the cornea, dentin and the intestinal more, as all GELITA® Collagen Peptides they provide wall – a vital component of our whole body. a number of physiological and technical benefits making them the perfect supplement to realize innovative product ideas in the fields of health, beauty and sports nutrition. Bioactive Collagen Peptides® Skin Health Fibroblasts VERISOL® Joint Health Chondrocytes FORTIGEL® Bone Health Osteoblasts/ FORTIBONE® Osteoclasts Ligaments/ Ligamentocytes/ TENDOFORTE® Tendons Tenocytes Osteoporosis Body Toning Muscle cells BODYBALANCE® resistance exercise Endurance Muscle cells PeptENDURE® endurance performance Normal bone matrix [4] Why to use GELITA ® Collagen Peptides? Which benefits provide GELITA ® Collagen Peptides? • Pure Food Protein (up to 98 % protein in dry matter) GELITA ® Collagen Peptides • Safe according to an excellent sensorial profile have Reg. (EC) No 853/2004 • Non Allergenic (Mammalian Source) mouth color • Clean label feeling • Non GMO Products turbidity • FDA GRAS status after (Docket Number 77N-0232) taste • KOSHER/HALAL 0 smell (bovine origin) salty sour GELITA ® Collagen Peptides have a consistent bitter 6 typical amino acid and nutritional profile and sweet are free from fat, sugar, cholesterol, purines and PEPTIPLUS® Soy protein additives. They offer clean-label opportunities. Whey protein Sensorial evaluation of PEPTIPLUS on a scale of: 0 = not noticable to® ,6 Whey = strong and Soy The powder and liquid form of Collagen Peptides show an excellent sensorial profile suitable for sophisticated applications like beverages or powder products. Technical Product Data PEPTIPLUS® XB aggl. Comprising PEPTIPLUS® XB aggl., PEPTIPLUS® XB (SA) aggl., PEPTIPLUS® XB (US) aggl., PEPTIPLUS® XB (NL) aggl., Product description: Application and Service: PEPTIPLUS® XB aggl. are highly purified PEPTIPLUS® XB aggl. is suitable for protein enrichment in food such Collagen Peptides from bovine skin. The as bars, gums and beverages. average molecular weight is between 2,500 – 4,000 g/mol. Shelf life: Under dry and odorless conditions PEPTIPLUS® XB aggl. can be Characteristics: stored in the original unopened packaging at ambient temperatures Nutritional profile Light colored, agglomerated powder with a (< 30°C) for 5 years without loss of quality. bulk density between 270 - 400 g/L. Nutrient Specifically neutral in taste and odor and Packages: Energy value (per 100g) excellently soluble in cold and warm water. Multi-ply paper bags with PE-liner containing 15 kg net. (average) PEPTIPLUS® XB aggl. is pure collagen : Fat 2 protein with an extremely low mineral of which Typical value content and is free of fat, cholesterol, Microbiological limits: carbohydrates, and dietary fibers. Chemical/Physical Data: -saturates 1,530 kJ (360 kcal) -trans fat 2 Parameter Parameter Test Method Value Total aerob. micro. count Cholesterol 0 g Protein content Kjeldahl (N x 5.55) 91 – 96 % 5 Carbohydrates Total yeast/mould count Amino acid composition Protein content based on GELITA method ≥ 97 % of which Sulfite re. anaer. spores dry substance 2 0 g Test Method Escherichia coli Amino acid Weight (%) Dry substance (105 °C, 16 h) GME3 91 – 96 % -sugars 0 g Ph. Eur./USP 2 Salmonella 2 Protein Ash (550°C) USP/GME 0.9 % 0 g Ph. Eur./USP Alanine 8.6 ≤ 6 Salt Arginine 7.3 pH (20 %, RT) Potentiometer 5.0 – 6.4 0 g AFNOR NF V59-106 Value Sodium < 1000 cfu/g Aspartic acid 5.8 Viscosity (20 %, 25°C) GELITA method 3.00 – 5.00 mPa s Ph. Eur./USP mod. Allergen information Vitamin D 0 g ISO 6579 < 100 cfu/g Glutamic acid 10.2 ≥ 90% below 425 µm (40 mesh) 90.0 g Particle distribution Sieve Test / DLS Calcium < 10 cfu/g Glycine 22.2 15% below 75 µm Allergens (REG (EU) No 1169/2011) / USDA ≤ 0.5 g negative / 10 g (200Iron mesh) Not a significant source Cereals containing gluten, namely wheat (such as spelt and Histidine 1.0 Khorasan wheat), rye, barley, oats, spelt, kamut or their negative / 25 g Peroxides Ph. Eur./GME ≤ 10Potassium mg/kg Not a significant source0.2 g Isoleucine 1.4 hybridized strains, and products thereof 2 Sulphur dioxide Ph. Eur./GME ≤ 10 mg/kg Not a significant source Crustaceans and products thereof Leucine 2.7 6The protein is calculated from the nitrogen content by Arsenic2 ICP-OPS ≤using 1.0 mg/kgthe factor 5.55 as describedNot a insignificant Jones, D.B. source (1941) Eggs and products thereof Lysine 3.6 US. Dept. Agric. Circ. 183 (revised). Cadmium2 ICP-OPS ≤ 0.1 mg/kg Fish and products thereof Hydroxylysine 1.6 Chromium2 ICP-OPS ≤ 10.0 mg/kg Peanuts and products thereof Methionine 0.9 contains Copper2 ICP-OPS Regulatory≤ 30.0 mg/kg Issues: Soybeans and products thereof Phenylalanine 2.1 2 Milk and products thereof (including lactose) No Mercury AAS PEPTIPLUS≤ 0.1 mg/kg Proline 12.7 Nuts, namely almonds, hazelnuts, walnuts, cashews, pecan 2 extremely low mineral content and is free of fat, Lead ICP-OPS ≤ 0.5 mg/kg® Hydroxyproline 11.9 cholesterol, carbohydrates, XB aggl. is puredietary collagen fibers proteinand GMO. with an nuts, Brazil nuts, pistachio nuts, macadamia or Queensland No 2 nuts, and products thereof Zinc ICP-OPS The product≤ 30.0 is mg/kg in accordance with FDA regulations, No Serine 3.2 HACCP, ISO9001:2015 and FSSC22000:2010. Celery and products thereof No Threonine 1.8 Classified as GRAS (Generally Regarded As Safe). Mustard and products thereof Furthermore, the product is in compliance with 2Reduced frequency testing in accordance to an internal quality program. No Tyrosine 0.8 regulation (EC) No. 852/2004 on the hygiene of Sesame seeds and products thereof The values given are based on average GELITA monitoring foodstuffsdata at the and time with of regulation printing. (EC) No. 853/2004, laying No 2.4 Sulphur dioxide and sulphites (E220 - E228) at concentrations of Valine These values are for information only. down specific hygiene rules for food of animal origin. 3 > 10 No GME, Gelatine Manufactures of Europe According to regulation (EC) No. 1829/2003 and mg/kg or > Lupin and products thereof 4determined due to national regulations and requirements regulation– not standard (EC) No. 1830/2003 the product has not to 10 5Average score for typical collagen
Load more

Recommended publications
  • Market Watch: Protein the Power of Protein Buyer's Guide
    Official Magazine of SupplySide® February 2015 $39 US foodproductdesign.com An Exclusive Digital-Only Issue PRESENTS PROTEIN 03 Market Watch: Protein 06 The Power of Protein 13 Buyer's Guide FEBRUARY 2015 SURVIVAL GUIDE: PROTEIN 03 06 11 13 Market Watch: Protein The Power of Protein Protein Fortification Buyer’s Guide to Strategies Market data on the use Protein considerations Protein of protein in food and and their role in functional Insight into protein A directory of protein beverage products. foods and beverages. fortification strategies. suppliers for the food and beverage industries. foodproductdesign.com Copyright © 2015 Informa Exhibitions LLC. All rights reserved. The publisher reserves the right to accept or reject any advertising or editorial material. Advertisers, and/or their agents, assume the responsibility for all content of published advertise- ments and assume responsibility for any claims against the publisher based on the advertisement. Editorial contributors assume responsibility for their published works and assume responsibility for any claims against the publisher based on the published work. Editorial content may not necessarily reflect the views of the publisher. Materials contained on this site may not be reproduced, modified, distributed, republished or hosted (either directly or by linking) without our prior written permission. You may not alter or remove any trademark, copyright or other notice from copies of content. You may, however, download material from the site (one machine readable copy and one print copy per page) for your personal, noncommercial use only. We reserve all rights in and title to all material downloaded. All items submitted to FOOD PRODUCT DESIGN become the sole property of Informa Exhibitions LLC.
    [Show full text]
  • Unit 2: Bones and Cartilage Structure and Types O0f
    CBCS 3RD SEM MAJOR ; PAPER 3026 UNIT 2: BONES AND CARTILAGE STRUCTURE AND TYPES 0F BONES AND CARTILAGE OSSIFICATION BONE GROWTH AND RESORPTION BY: DR. LUNA PHUKAN STRUCTURE AND TYPES 0F BONES The bones in the skeleton are not all solid. The outside cortical bone is solid bone with only a few small canals. The insides of the bone contain trabecular bone which is like scaffolding or a honey- comb. The spaces between the bone are filled with fluid bone marrow cells, which make the blood, and some fat cells A bone is a rigid organ that constitutes part of the vertebrate skeleton in animals. Bones protect the various organs of the body, produce red and white blood cells, store minerals, provide structure and support for the body, and enable mobility. Bones come in a variety of shapes and sizes and have a complex internal and external structure. They are lightweight yet strong and hard, and serve multiple functions Bone tissue (osseous tissue) is a hard tissue, a type of dense connective tissue. It has a honeycomb-like matrix internally, which helps to give the bone rigidity. Bone tissue is made up of different types of bone cells. Osteoblasts and osteocytes are involved in the formation and mineralization of bone; osteoclasts are involved in the resorption of bone tissue. Modified (flattened) osteoblasts become the lining cells that form a protective layer on the bone surface. The mineralised matrix of bone tissue has an organic component of mainly collagen called ossein and an inorganic component of bone mineral made up of various salts.
    [Show full text]
  • THE HISTOGENESIS of BONE by C
    THE HISTOGENESIS OF BONE By C. WITHERINGTON STUMP, M.D. From the Laboratory of the Royal College of Physicians, Edinburgh INTRODUCTION FEW processes in histogenesis have been the subject of so much controversy, as that of the development of bone. On reading over the literature, even incompletely, the conviction came with considerable force, that the chief cause of the inability of observers, to find agreement, lay in technical difficulties in obtaining satisfactory preparations for cytological study. The divergent opinions are accounted for by the singular absence of detailed work-a fact which has fostered and sustained a controversy into which there is no need to enter. Microscopic evidence of cell growth and change is yielded by slight morpho- logical variations in different individual cells. Slight differences in structure, and staining reaction, are the only factors by means of which variations can be determined. It is essential, with cells examined in a dead state, to have a standard of fixation which registers detailed and minute structure. Further, it is constantly to be borne in mind, that merely a phase of life is represented, through which the cell was passing at the time of its death. Especially is this so in actively growing, developing tissue, where many structural tendencies are manifested by the act of growth. Thus, in fixed primitive tissue, the ontogeny of any given cell is a matter of conjecture, and it can only be defined with any degree of certainty by an experienced observer. It would be redundant to attempt an historical survey of the contributions to the problem of osteogenesis.
    [Show full text]
  • Nomina Histologica Veterinaria, First Edition
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]
  • Foods of the Future Editorial Dear Reader, Movement Doesn’T Just Benefit People, It Also Helps Companies Stay Fit
    August 2015 UPTODATE The Newsletter for GELITA Customers #36 GELITA Symposium! Foods of the Future Editorial Dear reader, Movement doesn’t just benefit people, it also helps companies stay fit. This is why we are not satisfied with simply developing innovative products. We con- tinually contemplate how we can improve our processes. With our new spray dryer plant, for example, we are increasing our depth of production. We have also reorganized our purchasing structure from local to global. How you, as a customer benefit from this, Heinrich Schmidt, Vice President Global Procure- ment, explains in an interview. “Thinking outside the box” was the aim of the recent GELITA Food Symposium: In mid-June, product developers and marketing professionals from all over the world met to exchange ideas. The unconventional thinkers came up with aston- ishing ideas and reported on the startling results of their work. Would you have imagined that a round chocolate ball is perceived as tasting sweeter than a square chocolate bar? New on the market is GELITA®-VET AlfaGel. This innovative product helps to cure inflammations of the ear canal in dogs more simply. What dogs would say about it, we can only guess, but the feedback from veterinarians would suggest a joyous “WOOF” from our four-legged friends. Returning to movement: This will be much in demand in October at the GELITA The editors of uptodate spoke Trail Marathon in Heidelberg. Come and join us! There’s still time to train. with Heinrich Schmidt, With this in mind, keep moving. Vice President Global
    [Show full text]
  • Beauty in Liquid Form Editorial
    July 2012 UPTODATE The Newsletter for GELITA Customers #30 GELITA wellness drinks: Beauty in liquid form Editorial Dear Readers, Feeding a rapidly growing world population is going to be one of the most difficult challenges facing us in the future. This is no abstract theory, but a hard fact. By the year 2030 the demand for food will increase by 50 % and by 2050 it will have doubled. As such, the demand for high-quality collagen protein products will also increase – e. g. gelatine for foodstuffs and pharmaceuticals along with collagen peptides for protein enrichment and for functional performance in health and nutrition products. To further compound the challenge of a growing population, standards of living are also rising and as a result our eating habits are changing. We are living longer and we desire to stay healthy, active and attractive as we age. To support these trends, innovations in food, pharmaceutical and health and nutrition industries are required; and GELITA provides these innovative solutions. Beverages enhanced with GELITA’s special and optimized Bioactive Collagen Peptides® (VERISOL® for Beauty from Within and FORTIGEL® for Mobility) offer added value by increasing beauty and mobility on a sip-by-sip. In addition to maintaining youth and fitness, GELITA’s products provide sweet delicacies with their light, foamy or chewy forms and tender mouth feel. A topic on our agenda for quite some time” is the scarcity of raw materials. At GELITA we have a number of strategies intended to secure these valuable resources including supply partner - ships and joint ventures. Newly structured innovation processes and the resulting synergies are also part of our strategic initiatives.
    [Show full text]
  • L-1, Introduction to Orthopedic
    introduction Dr Hiba Abdulmoneim Definition • A bone is a rigid organ that constitutes part of the vertebrate skeleton • Bone tissue is a hard tissue, a type of dense connective tissue. It has a honeycomb-like matrix internally, which helps to give the bone rigidity. Bone tissue is made up of different types of bone cells • The mineralised matrix of bone tissue has an organic component of mainly collagen called ossein and an inorganic component of bone mineral made up of various salts. Bone tissue is a mineralized tissue of two types, cortical and cancellous bone. Other types of tissue found in bones include bone marrow, endosteum, periosteum, nerves, blood vessels and cartilage. structure functions • Provide structural support for the body • Provide protection of vital organs • Provide an environment for marrow (where blood cells are produced) • Act as a storage area for minerals (such as calcium) Synthetic • Cancellous bones contain bone marrow. Bone marrow produces blood cells in a process called hematopoiesis.Blood cells that are created in bone marrow include red blood cells, platelets and white blood cells Metabolic • Mineral storage — bones act as reserves of minerals important for the body, most notably calcium and phosphorus. • Growth factor storage — mineralized bone matrix stores important growth factors such as insulin-like growth factors, transforming growth factor, bone morphogenetic proteins and others. • Fat storage — the yellow bone marrow acts as a storage reserve of fatty acids. • Acid-base balance — bone buffers the blood against excessive pH changes by absorbing or releasing alkaline salts. • Detoxification — bone tissues can also store heavy metals and other foreign elements, removing them from the blood and reducing their effects on other tissues.
    [Show full text]
  • 45 Years GELITA Mexico
    July 2013 UPTODATE A Newsletter for GELITA Customers #32 Celebrations! 45 years GElita Mexico Editorial Dear Readers, To have a presence throughout the world while at the same time be connected to the customer; for GELITA this is more than just a goal. At the recent two-day “GELITA Sym- posium on Food, Health & Nutrition” in Heidelberg, we were able to validate this once again. We invited leading nutrition experts to discuss the trend-setting topic of proteins and communicated our current research. In discussions with our guests and global experts, we were able to further ascertain customer requirements. Global Vice President Sales Staffan Månsson expressed it thus: “We actually need 360° vision if we are to be successful with the customer as well as the supply side.” He counts on his staff to combine local competence with global thinking. As to how Staffan and his team manage to tap worldwide potential while maintaining efficient purchasing costs, you can read how in the interview on page 4. News from GELITA MEDICAL: GELITA-CEL® Fibrillar and GELITA-CEL® X-SORB are products that enhance opportunities in surgery. Safety, speed and efficiency are the major criteria here. The London hologram manufacturer, Colour Holographics Ltd., also requires for top quality e. g. in its safety and measurement technology by using high- quality GELITA photographic gelatine. The trend towards healthy gelatine products is now a worldwide occurrence: fortified gummies are the latest successful products in the Anniversary in Central America: health and nutrition
    [Show full text]
  • GELITA Gelatine for Art Casting
    January 2014 UPTODATE The Newsletter for GELITA Customers #33 Applications GELITA Gelatine for art casting Editorial Dear Reader, GELITA constantly brings new and innovative products into the market. However, how does our company manage to generate and promote such good ideas? And what makes a good idea an innovation? With these questions we have interviewed Hans-Ulrich Frech, Global Vice President Business Unit Collagen Peptides, Health & Nutrition, Medical and Dr. Alexander Raab, Global Vice President Business Unit Gelatine. What we can be said is: stringent checking is a principal component. More on this topic in the interview. The new product NOVOTEC® CL800 is a prime example of innovation by GELITA. The functional proteins in NOVOTEC® CL800 can be substituted for mineral oils in cooling lubricants, rendering these sustainable, more effective and less harmful to health. The demand for animal foods is increasing – as is the mindfulness of owners to do everything possible for the health of their beloved pets. GELITA has recognized this trend and has consequently developed a new dog food: PETAGILE®. The Bioactive Collagen Peptides® it contains counteract degenerative arthritis of their joints as well as significantly providing relief from symptoms. Further examples of GELITA innovations: The uptodate newsletter is now available The editors of uptodate interviewed on-line, under www.gelita-online.com, with all articles in English, German, Hans-Ulrich Frech and Dr. Alexander Portuguese and Spanish – plus additional pictures and videos.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,034,315 B2 Geistlich (45) Date of Patent: May 19, 2015
    USOO9034315B2 (12) United States Patent (10) Patent No.: US 9,034,315 B2 Geistlich (45) Date of Patent: May 19, 2015 (54) CELL-CHARGED MULTI-LAYER (2013.01); A61L 15/40 (2013.01); A61L 27/24 COLLAGEN MEMBRANE (2013.01); A61L 27/3804 (2013.01); A61L 27/3847 (2013.01); A61L 31/005 (2013.01); (75) Inventor: Peter Geistlich, Stansstad (CH) A61L 31/044 (2013.01); C12N 2533/54 (2013.01) (73) Assignee: ED. GEISTLICH SOEHNE AG FUER (58) Field of Classification Search CHEMISCHE INDUSTRIE, Wolhusen None (CH) See application file for complete search history. (*) Notice: Subject to any disclaimer, the term of this (56) References Cited patent is extended or adjusted under 35 U.S.C. 154(b) by 1099 days. U.S. PATENT DOCUMENTS 4,394,370 A 7/1983 Jefferies (21) Appl. No.: 11/509,826 4,516,276 A 5, 1985 Mittelmeier et al. (22) Filed: Aug. 25, 2006 (Continued) (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2007/OO31388A1 Feb. 8, 2007 AU 660045 6, 1995 AU 663150 9, 1995 Related U.S. Application Data (Continued) (63) Continuation-in-part of application No. 1 1/317.247, OTHER PUBLICATIONS filed on Dec. 27, 2005, which is a continuation-in-part of application No. 10/367,979, filed on Feb. 19, 2003, Mason, J.M. et al., Viral vector laboratory, NSUH. Manhasset, NY. now abandoned, which is a continuation-in-part of (CORR, Nov. 2000), 7 pages. (Continued) (Continued) (30) Foreign Application Priority Data Primary Examiner — Allison Fox (74) Attorney, Agent, or Firm — Rothwell, Figg, Ernst & Oct.
    [Show full text]
  • Often Copied, Never Matched!
    December 2017 UPTODATE The Newsletter for GELITA Customers #41 GELITA® gelatine Often copied, never matched! More on page 6 Editorial Dear reader, Innovation management is a cornerstone of successful companies. GELITA goes one step further and builds on a whole culture of innovation. “The culture we live and breathe is crucial for innovations to emerge at all”, confirms Wiebke Steinel, Manager Corporate Development, in an interview. The motto “Off the beaten track – inspiration for better food, nutrition and health” with which we hosted the GELITA Symposium in Heidelberg this fall, and attracted around 80 participants from all over the world, is also in keeping with this approach. One of the topics was a revolutionary technology that GELITA developed together with two other companies. The so-called “fast forward process” makes it possible to produce fruit gummies without starch molds. The new process not only improves hygiene, it also reduces production time many times over. Manufacturers of soft capsules can also optimize their production with our innovations and thus save time and money. With GELITA® EC, we launched an enteric gelatine product on the market that can be produced in one step. GELITA® EC is already the fourth product in our portfolio for the controlled release of active ingredients. Maybe this edition of uptodate will also set free a lot of good ideas when you read it? In this spirit we wish you a successful new year. Michael Teppner ® Global VP Marketing & Communication GELITA EC GELITA AG The perfect uptodate spoke with Wiebke Steinel, (dis)solution Corporate Development Manager Interview [3] NEWS “The customer CSR report, [12] new CFO, is at the beginning top 100 award, etc.
    [Show full text]
  • New Investigations Into a Historic Treatment: the Efficacy of Gelatin As an Adhesive for Earthen Finishes at Mesa Verde National Park Emily M
    University of Pennsylvania ScholarlyCommons Theses (Historic Preservation) Graduate Program in Historic Preservation 2011 New Investigations into a Historic Treatment: The Efficacy of Gelatin as an Adhesive for Earthen Finishes at Mesa Verde National Park Emily M. Aloiz University of Pennsylvania Follow this and additional works at: http://repository.upenn.edu/hp_theses Part of the Historic Preservation and Conservation Commons Aloiz, Emily M., "New Investigations into a Historic Treatment: The Efficacy of Gelatin as an Adhesive for Earthen Finishes at Mesa Verde National Park" (2011). Theses (Historic Preservation). 178. http://repository.upenn.edu/hp_theses/178 Suggested Citation: Aloiz, Emily M. (2011). New Investigations into a Historic Treatment: The Efficacy of Gelatin as an Adhesive for Earthen Finishes at Mesa Verde National Park. (Masters Thesis). University of Pennsylvania, Philadelphia, PA. This paper is posted at ScholarlyCommons. http://repository.upenn.edu/hp_theses/178 For more information, please contact [email protected]. New Investigations into a Historic Treatment: The fficE acy of Gelatin as an Adhesive for Earthen Finishes at Mesa Verde National Park Abstract This thesis comes out of years of work beginning in 1994 undertaken by Frank Matero and the University of Pennsylvania to stabilize the earthen surface finishes of Mesa Verde National Park in Southwestern Colorado. The aim of this research is to better understand the performance and deterioration mechanisms for gelatin treatments used to reattach earthen plasters and washes. Threats to the treatment method include biodeterioration and failure due to wet-dry cycles and humidity fluctuations. The da hesive’s durability to these weathering phenomena was researched and evaluated through testing proxy samples in the Architectural Conservation Laboratory of the University of Pennsylvania.
    [Show full text]